Search for: "Hospira, Inc." Results 41 - 60 of 287
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2015, 3:50 am
 Another two were killed off as reported here (some claims survived in one patent, but these are apparently not of concern to Hospira); this is currently under appeal.The present case Hospira UK Ltd v Genentech Inc [2015] EWHC 1796 (Pat) concerns EP (UK) 1037926, which concerns a combination of trastuzumab with another favourite of pharmaceutical litigation, taxol (and other taxanes). [read post]
23 May 2011, 4:34 pm by David M. Fry
May 4, 2011), Special Master Poppiti recently denied defendant Hospira, Inc.'s motion for a protective order. [read post]
7 Feb 2011, 4:30 am by Laura Simons
Not too long ago, The Wall Street Journal Law Blog reported that drugmaker Hospira, Inc., based in Lake Forest, Illinois, will permanently cease production of sodium thiopental, an anesthetic that is a key component for the lethal injection drug combinations used in capital punishment. [read post]
25 Nov 2015, 10:40 am by Gene Quinn
Hospira, Inc., which was decided by Judges Dyk, Wallach, and Hughes on July 2, 2015. [read post]
25 Sep 2021, 9:04 pm by Patent Docs
Hospira, Inc., affirming a finding of unenforceability of a patent for inequitable conduct, inferring intent based in part on inconsistent representations that were made by the patentee to the U.S. [read post]
23 Apr 2012, 2:21 pm
In fact, our attorneys brought a case against Orion Research Inc. and Baxter Health Care Corporation for a flawed test for the genetic disease cystic fibrosis. [read post]
9 Apr 2012, 4:00 pm by Courtenay Brinckerhoff
Hospira, Inc., the Federal Circuit upheld the district court’s finding that two of the Orange Book listed patents for Sanofi Aventis’ cancer drug Taxotere are unenforceable for inequitable conduct. [read post]
26 Jun 2017, 11:27 am by Jay W. Belle Isle
Over concerns of sterility, Hospira Inc., a Pfizer company, has voluntarily recalled three injectable products, as of June 15, 2017. [read post]
13 Jul 2015, 10:00 pm by Courtenay C. Brinckerhoff
Hospira, Inc., the Federal Circuit held that a transaction with a contract manufacturer gave rise to an on sale bar that invalidated The Medicines Company’s Angiomax® patents. [read post]
6 Jan 2008, 9:07 pm
Hospira, Inc. 2:07-cv-08137; filed December 14, 2007 in the Central District of California... [read post]
2 Sep 2021, 9:15 am by IPWatchdog
Belcher brought the suit against Hospira, Inc. for infringement of the ‘197 patent under the Hatch-Waxman Act, but the district court found that the Belcher Chief Science Officer withheld... [read post]